Valuation: RAMM Pharma Corp.

Market Cap 1.19M 867K 743K 695K 636K 82.96M 1.21M 8.21M 3.2M 41.68M 3.26M 3.18M 138M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 342K 293K 274K 251K 32.69M 477K 3.24M 1.26M 16.42M 1.28M 1.25M 54.31M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
+17.49%+17.49% - - 867K
+0.88%+6.38%+76.86%+128.23% 1,119B
+1.07%+3.80%+51.03%+61.48% 651B
+1.20%+6.21%+26.47%+76.45% 468B
+1.02%+5.77%+43.09%+47.70% 374B
+0.85%+4.07%+23.88%+41.58% 302B
+1.26%+6.81%+1.59%+14.67% 259B
+1.88%+5.81%+48.54%+68.52% 238B
+1.59%+2.09%-15.52%-52.29% 208B
+1.87%+5.61%+25.81%+92.42% 181B
Average +2.91%+4.97%+31.31%+53.20% 422.21B
Weighted average by Cap. +1.14%+5.09%+44.31%+72.55%

Financials

2024 2025
Net sales 4.34M 3.15M 2.7M 2.53M 2.31M 302M 4.4M 29.86M 11.64M 152M 11.84M 11.58M 501M 3.36M 2.44M 2.09M 1.96M 1.79M 234M 3.41M 23.11M 9.01M 117M 9.16M 8.97M 388M
Net income -16.5M -11.98M -10.27M -9.61M -8.79M -1.15B -16.72M -113M -44.26M -576M -45M -44.02M -1.91B -8.91M -6.47M -5.54M -5.19M -4.75M -619M -9.03M -61.28M -23.9M -311M -24.3M -23.77M -1.03B
Net Debt -626K -454K -389K -364K -333K -43.48M -634K -4.3M -1.68M -21.84M -1.71M -1.67M -72.25M -723K -525K -450K -421K -386K -50.27M -733K -4.98M -1.94M -25.25M -1.97M -1.93M -83.53M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-